FOXP3 and melanoma: There was no significant difference in the frequency of CD4+ and CD8+ T-cells between the two cohorts, except for the frequency of regulatory T-cells (Tregs, as defined by CD25+ Foxp3+ CD4+ cells [18]) which was lower in melanoma patients.